Picture of Oncozenge AB logo

ONCOZ — Oncozenge AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: OncoZenge To Receive Decision On CTA By May 29

May 19 (Reuters) - Oncozenge AB ONCOZ.ST:

ONCOZENGE PROVIDES REGULATORY UPDATE ON BUPIZENGE PHASE III TRIAL

TO RECEIVE FINAL DECISION ON BUPIZENGE PHASE III TRIAL CTA NO LATER THAN MAY 29, 2026

Source text: ID:nMFN6ks9Yd

Further company coverage: ONCOZ.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Oncozenge AB

See all news